669 related articles for article (PubMed ID: 34932874)
41. Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant: A Systematic Review and Meta-Analysis.
Manothummetha K; Chuleerarux N; Sanguankeo A; Kates OS; Hirankarn N; Thongkam A; Dioverti-Prono MV; Torvorapanit P; Langsiri N; Worasilchai N; Moonla C; Plongla R; Garneau WM; Chindamporn A; Nissaisorakarn P; Thaniyavarn T; Nematollahi S; Permpalung N
JAMA Netw Open; 2022 Apr; 5(4):e226822. PubMed ID: 35412626
[TBL] [Abstract][Full Text] [Related]
42. Evaluating clinical effectiveness of SARS-CoV-2 vaccine in solid organ transplant recipients: A propensity score matched analysis.
Tucker M; Azar MM; Cohen E; Gan G; Deng Y; Foppiano Palacios C; Malinis M
Transpl Infect Dis; 2022 Aug; 24(4):e13876. PubMed ID: 35684932
[TBL] [Abstract][Full Text] [Related]
43. A Systematic Review and Meta-Analysis of Serologic Response following Coronavirus Disease 2019 (COVID-19) Vaccination in Solid Organ Transplant Recipients.
Sakuraba A; Luna A; Micic D
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016444
[TBL] [Abstract][Full Text] [Related]
44. Tixagevimab/cilgavimab pre-exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the omicron wave.
Al Jurdi A; Morena L; Cote M; Bethea E; Azzi J; Riella LV
Am J Transplant; 2022 Dec; 22(12):3130-3136. PubMed ID: 35727916
[TBL] [Abstract][Full Text] [Related]
45. Vaccination Against SARS-CoV-2 in Lung Transplant Recipients: Immunogenicity, Efficacy and Safety.
Svorcova M; Novysedlak R; Lischke R; Vachtenheim J; Strizova Z
Front Immunol; 2022; 13():906225. PubMed ID: 35720376
[TBL] [Abstract][Full Text] [Related]
46. Immunogenicity, Safety, and Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infections After Coronavirus Disease 2019 Vaccination in Organ Transplant Recipients: A Prospective Multicenter Canadian Study.
Kabbani D; Yotis DM; Ferreira VH; Shalhoub S; Belga S; Tyagi V; Ierullo M; Kulasingam V; Hébert MJ; West L; Delisle JS; Racine N; De Serres SA; Cardinal H; Dieudé M; Humar A; Kumar D
Open Forum Infect Dis; 2023 May; 10(5):ofad200. PubMed ID: 37213422
[TBL] [Abstract][Full Text] [Related]
47. Outcome of COVID-19 in Kidney Transplant Recipients Through the SARS-CoV-2 Variants Eras: Role of Anti-SARS-CoV-2 Monoclonal Antibodies.
Papadimitriou-Olivgeris M; Cipriano A; Guggisberg N; Kroemer M; Tschopp J; Manuel O; Golshayan D
Transpl Int; 2022; 35():10721. PubMed ID: 36267693
[TBL] [Abstract][Full Text] [Related]
48. Antispike monoclonal antibodies for prevention and treatment of coronavirus disease-2019 in solid organ transplant recipients.
Yetmar ZA; Bhaimia E; Razonable RR
Curr Opin Organ Transplant; 2022 Aug; 27(4):269-276. PubMed ID: 36354253
[TBL] [Abstract][Full Text] [Related]
49. Association of COVID-19 Vaccination With Risk of COVID-19 Infection, Hospitalization, and Death in Heart Transplant Recipients.
Peters LL; Raymer DS; Pal JD; Ambardekar AV
JAMA Cardiol; 2022 Jun; 7(6):651-654. PubMed ID: 35475896
[TBL] [Abstract][Full Text] [Related]
50. Coronavirus disease 2019 vaccination is protective of clinical disease in solid organ transplant recipients.
Aslam S; Liu J; Sigler R; Syed RR; Tu XM; Little SJ; De Gruttola V
Transpl Infect Dis; 2022 Apr; 24(2):e13788. PubMed ID: 34989104
[TBL] [Abstract][Full Text] [Related]
51. A Review of Treatment and Prevention of Coronavirus Disease 2019 among Solid Organ Transplant Recipients.
Buehrle DJ; Sutton RR; McCann EL; Lucas AE
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578287
[TBL] [Abstract][Full Text] [Related]
52. Outcome of SARS-CoV-2 variant breakthrough infection in fully immunized solid organ transplant recipients.
Almaghrabi RS; Alhamlan FS; Dada A; Al-Tawfiq JA; Al Hroub MK; Saeedi MF; Alamri M; Alhothaly B; Alqasabi A; Al-Qahtani AA; Al-Omari A; Alshukairi AN
J Infect Public Health; 2022 Jan; 15(1):51-55. PubMed ID: 34906898
[TBL] [Abstract][Full Text] [Related]
53. COVID-19 vaccination hesitancy and associated factors among solid organ transplant recipients in China.
Chen T; Li X; Li Q; Huang L; Cai Q; Wang Y; Jiang Y; Xu Q; Lv Q; Wang J
Hum Vaccin Immunother; 2021 Dec; 17(12):4999-5006. PubMed ID: 34586945
[TBL] [Abstract][Full Text] [Related]
54. Monoclonal Antibody Treatment of Breakthrough COVID-19 in Fully Vaccinated Individuals with High-Risk Comorbidities.
Bierle DM; Ganesh R; Tulledge-Scheitel S; Hanson SN; Arndt LL; Wilker CG; Razonable RR
J Infect Dis; 2022 Feb; 225(4):598-602. PubMed ID: 34791298
[TBL] [Abstract][Full Text] [Related]
55. Risk of severe COVID in solid organ transplant recipient.
Barreiro P; Candel FJ; Carretero MM; San Román J
Rev Esp Quimioter; 2023 Nov; 36 Suppl 1(Suppl 1):15-17. PubMed ID: 37997864
[TBL] [Abstract][Full Text] [Related]
56. Clinical effectiveness of COVID-19 vaccination in solid organ transplant recipients.
Aslam S; Adler E; Mekeel K; Little SJ
Transpl Infect Dis; 2021 Oct; 23(5):e13705. PubMed ID: 34324256
[TBL] [Abstract][Full Text] [Related]
57. COVID-19 in solid organ transplant recipients: a single-center experience.
Hoek RAS; Manintveld OC; Betjes MGH; Hellemons ME; Seghers L; Van Kampen JAA; Caliskan K; van de Wetering J; van den Hoogen M; Metselaar HJ; Hesselink DA;
Transpl Int; 2020 Sep; 33(9):1099-1105. PubMed ID: 32460390
[TBL] [Abstract][Full Text] [Related]
58. First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study.
Tschopp J; L'Huillier AG; Mombelli M; Mueller NJ; Khanna N; Garzoni C; Meloni D; Papadimitriou-Olivgeris M; Neofytos D; Hirsch HH; Schuurmans MM; Müller T; Berney T; Steiger J; Pascual M; Manuel O; van Delden C;
Am J Transplant; 2020 Oct; 20(10):2876-2882. PubMed ID: 32412159
[TBL] [Abstract][Full Text] [Related]
59. Coronavirus Disease-19: Disease Severity and Outcomes of Solid Organ Transplant Recipients: Different Spectrums of Disease in Different Populations?
Ali T; Al-Ali A; Fajji L; Hammad E; Nazmi A; Alahmadi I; Aleid H; Ullah A; Shah Y; Broering D
Transplantation; 2021 Jan; 105(1):121-127. PubMed ID: 32852405
[TBL] [Abstract][Full Text] [Related]
60. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A
Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
